Diagnostic of latent tuberculosis: Clarification is necessary;Diagnostic et traitement de l'infection tuberculeuse latente: Un texte qui doit être clerifié pour le rendre applicable

Revue des Maladies Respiratoires

Volumn 21, Issue 2 PART 1, 2004, Pages 255-258

  Cadranel, J ^a   Delacourt, C ^b  

^a HÔPITAL TENON   (France)

^b Centre Intercommunal   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; RIFAMPICIN;

CHEMOPROPHYLAXIS; EDITORIAL; FRANCE; HUMAN; INCIDENCE; LUNG INFECTION; LUNG TUBERCULOSIS; THORAX RADIOGRAPHY; VACCINATION;

EID: 3042761221     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71283-8     Document Type: Editorial

References (21)

1. Groupe de travail du Conseil Supérieur d'Hygiène Publique de France: Prévention et prise en charge de la tuberculose en France. Rev Mal Respir 2003;20:7S7-7S105.
2. Revaccination par le BCG: deux avis du Conseil Supérieur d'Hygiène Publique de France. Info Respiration 2003;54:14-5.
3. Société de Pneumologie de Langue Française: Conférence d'Experts «Tuberculose» 2004. Rev Mal Respir 2004;21:414-20; http://www.splf.org/rmr/accesLibre/recosTuberculose.htm
4. Sarasin FP, Perrier A, Rochat T: Isoniazid preventive therapy for pulmonary tuberculosis sequelae: which patients up to which age? TuberLungDis 1995;76:394-400.
5. American Thoracic Society: Targeted tuberculin testing and treatment of latent tuberculosis tuberculosis infection. Am J Respir Crit Care Med 2000;161:221-47.
6. McKenna MT, McCtay E, Onorato I: The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995;332:1071-6.
7. Starke JR, Jacobs RF, Jereb J: Resurgence of tuberculosis in children. J Pediatr 1992;120:839-55.
8. Comstock GW, Livesay VT, Woolpert SF: The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8.
9. Gajalakshmi V, Peto R, Kanaka TS, Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43,000 adult male deaths and 35,000 controls. Lancet 2003;362:507-15.
10. Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970;17:28-106.
11. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM: Isoniazid for preventing tuberculosis in non HIV infected persons [Cochrane Review]. In: The Cochrane Library, Issue 2, 2003, Oxford: Update Software.
12. Comstock GW: How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-50.
13. Kopanoff DE, Snider DE, Jr, Caras GJ: Isoniazid-related hepatitis: a US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991-1001.
14. Nolan CM, Goldberg SV, Buskin SE: Hepatotoxicity associated with isoniazid preventive therapy: a 7 year survey from a public health tuberculosis clinic. JAMA 1999;281:1014-8.
15. LoBue PA, Moser KS: Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003;168:443-7.
16. Centers for Disease Control and Prevention (CDC); American Thoracic Society: Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:735-9.
17. Hong Kong chest service/tuberculosis research centre, Madras/british medical research council: A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimen in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992;145:36-41.
18. Ormerod LP: Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998;169-71.
19. McNab BD, Marciniuk DD, Alvi RA, Tan L, Hoeppner VH: Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in canadian plains aborigenes. Am J Respir Crit Care Med 2000;167: 989-93.
20. La tuberculose en France: comment arrêter l'épidémie actuelle? Texte du groupe de synthèse. Conférence d'experts sur la tuberculose. Med Mal Infect 1995;25:448-53.
21. Joint Tuberculosis Committee of the British Thoracic Society: Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48.